By SA Transcripts:
Kirkland's, Inc. (NASDAQ:KIRK)
Q2 2014 Results Earnings Conference Call
August 21, 2014, 11:00 AM ET
Tripp Sullivan - SCR Partners
Robert Alderson - CEO
Mike Madden - President and COO
Adam Holland -...
Kindred Biosciences (NASDAQ: KIN) shares dipped 28.36% to $10.18 after the company reported that its pivotal field study (KB010) of CereKin did not meet its primary endpoint.
Ampio Pharmaceuticals (NYSE: AMPE) shares fell 19.84% to $5.98 after...
Kindred Biosciences, Inc. (NASDAQ: KIN)
announced that its pivotal field study (KB010) of CereKin, an interleukin-1 inhibitor for the control of pain and inflammation associated with osteoarthritis in dogs, did not meet its primary...
By Investment Moto:
Kirkland's Inc. (NASDAQ:KIRK) is a specialty retailer of home décor with 324 stores across 35 U.S. states. Recently, significant fluctuation has been observed in Kirkland's share price which makes it difficult to assess...
Kirkland's, Inc. (KIRK)
Q1 2014 Results Earnings Conference Call
May 22, 2014; 11:00 a.m. ET
Robert Alderson - President & Chief Executive Officer
Mike Madden - Senior Vice President & Chief Financial Officer
Kirkland's, Inc. (NASDAQ: KIRK) today announced that it will be making a
presentation at the Wedbush 2013 California Dreamin’ Consumer Conference
on Tuesday, December 10, 2013, at 8:35 a.m. ET.
The live simulcast of...
Oops! Unable to complete your request. Please refresh your browser.